Table 1.

Inclusion and exclusion criteria used for patient recruitment and study inclusion.

Inclusion criteria	1. Patients between the ages of 18 and 75 with suspected or confirmed liver disease
	2. Patients who have received a Fibroscan assessment as part of their standard of care within <1 month of the oncoustics scan
	3. Patients with the ability to understand and willingness to sign a written informed consent document
Exclusion criteria	Recruitment exclusion:
	1. Patients <18 or >75 years of age
	2. Patients unable to consent
	3. Patients participating in a clinical trial that may alter the state of liver tissue in the time between the Fibroscan assessment and POCUS scan
	Study exclusion:
	1. Patients with concomitant liver diseases, such as fibrosis, cirrhosis, HCC, cholangiocarcinoma, metastatic cancer, cysts, or nodules
	2. Patients who have received a liver biopsy <1 month prior to the POCUS scan
	3. Patients with missing or incomplete demographic, anthropometric or clinical information
	4. Patients with S1 or S2 level steatosis according to CAP interpretation guides